NASDAQ : RLMD

Relmada Therapeutics, Inc.

$5.46 USD

-$0.75 (-12.08%)

Volume
1.87M
Average Volume
1.61M
Market Capitalization
$572.7M
P/E Ratio
-4.92
Dividend Yield
0.00%
Price Target
$10.00
Year High
$8.00
Year Low
$0.55
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$18.26

RLMD Estimated and Actual Revenue by Quarter

RLMD Estimated and Actual EPS by Quarter

RLMD Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 0 -27.71M -27.71M -27.71M - - -
2027-09-30 0 -25.55M -25.55M -25.55M - - -
2027-06-30 0 -23.38M -23.38M -23.38M - - -
2027-03-31 0 -21.65M -21.65M -21.65M - - -
2026-12-31 0 -18.27M -18.27M -18.27M - - -
2026-09-30 0 -18.83M -15.82M -17.33M - - -
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 0 - - - 1 -0.32 -0.32 -0.32
2027-09-30 0 - - - 1 -0.295 -0.295 -0.295
2027-06-30 0 - - - 1 -0.27 -0.27 -0.27
2027-03-31 0 - - - 1 -0.25 -0.25 -0.25
2026-12-31 0 - - - 1 -0.21097 -0.21097 -0.21097
2026-09-30 0 - - - 3 -0.21748 -0.18268 -0.20008